For the Inventor, By the Inventor

Enter inventor name

Mills River, NC, United States of America

David William Bristol

USPTO Granted Patents = 31

Average Co-Inventor Count = 3.5

ph-index = 9

Forward Citations = 189(Granted Patents)

Location History:

Mills River, NC (US) (2010 - 2016)
Pisgah Forest, NC (US) (1998 - 2019)

Company Filing History:

Pisgah Laboratories, Inc.

Pisgah Labs, Inc.

Micro Flo Company

Pisgah National Laboratories, Inc.

Years Active: 1998-2019

Loading Chart...

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10183001 - Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features (2019-01-22),

2. 9421266 - Safety of pseudoephedrine drug products (2016-08-23),

3. 9226925 - Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder (2016-01-05),

4. 8980880 - Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder (2015-03-17),

5. 8957067 - Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder (2015-02-17),

6. 8940729 - Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder (2015-01-27),

7. 8921386 - Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties (2014-12-30),

8. 8916587 - Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder (2014-12-23),

9. 8912217 - Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder (2014-12-16),

10. 8883863 - Safety of psuedoephedrine drug products (2014-11-11),

11. 8859622 - Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance (2014-10-14),

12. 8846766 - Abuse-deterrent methadone for the safe treatment of drug abuse and pain relief (2014-09-30),

13. 8748416 - Opioid salts and formulations exhibiting anti-abuse and anti-dumping properties (2014-06-10),

14. 8716337 - Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder (2014-05-06),

15. 8716278 - Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder (2014-05-06),

Title: David William Bristol: Innovator in Pharmaceutical Patents

Introduction: David William Bristol, based in Mills River, NC, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 31 patents. His innovative approach has led to the development of medications with enhanced safety features, particularly in the context of opioid treatment and attention deficit hyperactivity disorder.

Latest Patents: Among his significant advancements, Bristol's latest patents include an abuse deterrent drug product designed for opioid and ADHD medications. This product features a unique matrix that incorporates a drug substance defined as a 1:1 salt of a pharmaceutically active compound combined with BNDO. Additionally, he has patented safety enhancements for pseudoephedrine drug products, integrating drug substances that consist of an amine-containing pharmaceutically active compound, along with various additives such as alditol acetals and aromatic organic acids.

Career Highlights: David's career is marked by his tenure at Pisgah Laboratories, Inc. and Pisgah Labs, Inc., where he utilized his expertise to push the boundaries of pharmaceutical innovation. His dedicated work has led to creating safer drug formulations that help combat issues surrounding drug abuse and ensure patient safety.

Collaborations: Throughout his career, Bristol has collaborated with notable professionals in the field, including Clifford Riley King and Stephen G D'Ambrosio. These partnerships have enhanced his research capabilities, allowing for a collective advancement in the development of innovative pharmaceutical solutions.

Conclusion: David William Bristol stands out as a vital figure in pharmaceutical innovation, with a significant number of patents focused on drug safety and efficacy. His work continues to impact the industry, making strides towards safer medication practices that address critical health concerns.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…